Dr. Alexander Pantelyat, MD

Dr. Pantelyat practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Pantelyat's NPI, 1295990554, was assigned on July 25, 2008. Dr. Pantelyat graduated from Temple University School of Medicine in 2008. Dr. Pantelyat holds Maryland license D77954.

Dr. Pantelyat's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Pantelyat's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Pantelyat is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Pantelyat to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pantelyat practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Pantelyat's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Pantelyat's licenses on file in 2 states: Maryland and Pennsylvania.

CMS data shows 672 Medicare services from Dr. Pantelyat across 15 procedure codes in 2024, for 172 Medicare patients. Medicare paid $43,626 for them.

CMS counts 172 Medicare patients who saw Dr. Pantelyat in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pantelyat's median patient age at 72, with 48% women.

In 2024, Dr. Pantelyat wrote 385 Medicare Part D claims for 89 patients. 91% of them were for generic drugs. CMS names the drug for 261 of them, across 10 drugs with 11 or more claims each, at $11,008 in total drug cost. In 2023, CMS named 390 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Pantelyat for performance year 2024, reported as part of a group. CMS lists Dr. Pantelyat as offering telehealth.

Dmand AI links 95 papers to Dr. Pantelyat, published from 2014 to 2025. 2024 was the busiest year, with 15. The most frequent topics are Parkinson Disease, Supranuclear Palsy, Progressive and Brain. Dr. Pantelyat has published most often in Mov Disord. Dr. Pantelyat's most frequent co-authors are Liana Shapiro Rosenthal, MD, Ted Murray Dawson, MD and Irene Litvan, MD.

CMS Open Payments shows 29 general payments to Dr. Pantelyat from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 86% of the total. Biogen, Inc. paid the most, $12,583.

Dr. Pantelyat graduated from Temple University School of Medicine in 2008.